RespInnovation SAS

Endorse Company
About Us RespInnovation SAS designs, develops and markets a second generation of medical device technology based on High Frequency Chest Wall Oscillation (HFCWO) Therapy for the treatment of many diseases with chronic obstruction of the lungs, damage to the bronchi that result in chronic infection and production of significant amounts of exudative infectious mucus that must be eliminated from the lungs and bronchi, or neurodegenerative diseases that prevent patients from effectively clearing their lungs of even normal amounts of secretions. This device is very effective to release the lung airways of mucus and help patients expectorate. It is suitable for home care and hospital.

Products